Astroglia in neurological diseases

Future Neurology

Volumn 8, Issue 2, 2013, Pages 149-158

  Verkhratsky, Alexei ^a,b,c,d   Rodríguez, José J ^b,c,d   Parpura, Vladimir ^b,c,e,f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^e University of Alabama at Birmingham   (United States)

^f University of Rijeka   (Croatia)

Author keywords

Alexander disease; Alzheimer's disease; amyotrophic lateral sclerosis; astroglia; astroglial atrophy; astrogliosis; ischemia; neurodegeneration; neuropathology; stroke

Indexed keywords

ALEXANDER DISEASE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTOSIS; ATROPHY; CELL FUNCTION; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; EPILEPSY; GLIA CELL; HEAVY METAL POISONING; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; HYPERTROPHY; MACROGLIA; MAMMAL; MENTAL DISEASE; METABOLIC DISORDER; MIGRAINE; NEUROLOGIC DISEASE; NIEMANN PICK DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; WERNICKE ENCEPHALOPATHY;

EID: 84874612036     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.12.90     Document Type: Review

References (93)

1. Verkhratsky A. Physiology of neuronal-glial networking. Neurochem. Int. 57(4), 332-343 (2010).
2. Physiology and Pathophysiology of Neuroglia. Verkhratsky A, Butt A (Eds). Wiley, Chichester, UK (2013).
3. Verkhratsky A, Parpura V, Rodriguez JJ. Where the thoughts dwell: the physiology of neuronal-glial 'diffuse neural net'. Brain Res. Rev. 66(1-2), 133-151 (2011).
4. Neuroglia (3rd Edition). Kettenmann H, Ransom BR (Eds). Oxford University Press, Oxford, UK (2012).
5. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10(11), 1387-1394 (2007).
6. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol. Rev. 91(2), 461-553 (2011).
7. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145 (2009).
8. Hanani M. Satellite glial cells in sympathetic and parasympathetic ganglia: in search of function. Brain Res. Rev. 64(2), 304-327 (2010).
9. Gulbransen BD, Sharkey KA. Novel functional roles for enteric glia in the gastrointestinal tract. Nat. Rev. Gastroenterol. Hepatol. 9(11), 625-632 (2012).
10. Virchow R. Die Cellularpathologie in ihrer Begründung auf physiologische and pathologische Gewebelehre. Zwanzig Vorlesungen gehalten während der Monate Februar, März und April 1858 im pathologischen Institut zu Berlin. August Hirschwald, Berlin, Germany (1858).
11. Kettenmann H, Verkhratsky A. Neuroglia: the 150 years after. Trends Neurosci. 31(12), 653-659 (2008).
12. Verkhratsky A, Sofroniew MV, Messing A et al. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro. 4(3), e00082 (2012).
13. Parpura V, Heneka MT, Montana V et al. Glial cells in (patho)physiology. J. Neurochem. 121(1), 4-27 (2012).
14. Nedergaard M, Rodriguez JJ, Verkhratsky A. Glial calcium and diseases of the nervous system. Cell. Calcium 47(2), 140-149 (2010).
15. Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A. Glia: the fulcrum of brain diseases. Cell Death Differ. 14(7), 1324-1335 (2007).
16. De Keyser J, Mostert JP, Koch MW. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 267(1-2), 3-16 (2008).
17. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5(5), 347-360 (2004).
18. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat. Neurosci. 10(11), 1369-1376 (2007).
19. Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 22(5), 208-215 (1999).
20. Halassa MM, Fellin T, Haydon PG. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med. 13(2), 54-63 (2007).
21. Nedergaard M, Verkhratsky A. Artifact versus reality - how astrocytes contribute to synaptic events. Glia 60(7), 1013-1023 (2012).
22. Hertz L, Zielke HR. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 27(12), 735-743 (2004).
23. Hassel B, Brathe A. Neuronal pyruvate carboxylation supports formation of transmitter glutamate. J. Neurosci. 20(4), 1342-1347 (2000).
24. Kirischuk S, Parpura V, Verkhratsky A. Sodium dynamics: another key to astroglial excitability? Trends Neurosci. 35(8), 497-506 (2012).
25. Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 11(5), 400-407 (2005).
26. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32(12), 638-647 (2009).
27. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 119(1), 7-35 (2010).
28. Robel S, Berninger B, Gotz M. The stem cell potential of glia: lessons from reactive gliosis. Nat. Rev. Neurosci. 12(2), 88-104 (2011).
29. Alexander WS. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 72(3), 373-381 (1949).
30. Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE. Alexander disease. J. Neurosci. 32(15), 5017-5023 (2012).
31. Prust M, Wang J, Morizono H et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology 77(13), 1287-1294 (2011).
32. Takano T, Oberheim N, Cotrina ML, Nedergaard M. Astrocytes and ischemic injury. Stroke 40(Suppl. 3), S8-S12 (2009).
33. Vangeison G, Rempe DA. The Janus-faced effects of hypoxia on astrocyte function. Neuroscientist 15(6), 579-588 (2009).
34. Zhao Y, Rempe DA. Targeting astrocytes for stroke therapy. Neurotherapeutics 7(4), 439-451 (2010).
35. Szydlowska K, Tymianski M. Calcium, ischemia and excitotoxicity. Cell. Calcium 47(2), 122-129 (2010).
36. Danbolt NC. Glutamate uptake. Progr. Neurobiol. 65, 1-105 (2001).
37. Tanaka J, Toku K, Zhang B, Ishihara K, Sakanaka M, Maeda N. Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28(2), 85-96 (1999).
38. Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience 129(4), 1045-1056 (2004).
39. Parpura V, Grubisic V, Verkhratsky A. Ca(2+) sources for the exocytotic release of glutamate from astrocytes. Biochim. Biophys. Acta 1813(5), 984-991 (2011).
40. Malarkey EB, Parpura V. Mechanisms of glutamate release from astrocytes. Neurochem. Int. 52(1-2), 142-154 (2008).
41. Ding S, Wang T, Cui W, Haydon PG. Photothrombosis ischemia stimulates a sustained astrocytic Ca2+ signaling in vivo. Glia 57(7), 767-776 (2009).
42. Lin JH, Weigel H, Cotrina ML et al. Gap-junction-mediated propagation and amplification of cell injury. Nat. Neurosci. 1(6), 494-500 (1998).
43. Leão AAP. Spreading depression of activity in the cerebral cortex. J. Neurophysiol. 7, 359-390 (1944).
44. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat. Med. 17(4), 439-447 (2011).
45. Eikermann-Haerter K, Ayata C. Cortical spreading depression and migraine. Curr. Neurol. Neurosci. Rep. 10(3), 167-173 (2010).
46. Leo L, Gherardini L, Barone V et al. Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet. 7(6), e1002129 (2011).
47. Sugaya E, Takato M, Noda Y. Neuronal and glial activity during spreading depression in cerebral cortex of cat. J. Neurophysiol. 38(4), 822-841 (1975).
48. Nedergaard M, Cooper AJ, Goldman SA. Gap junctions are required for the propagation of spreading depression. J. Neurobiol. 28(4), 433-444 (1995).
49. Brusilow SW, Koehler RC, Traystman RJ, Cooper AJ. Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 7(4), 452-470 (2010).
50. Butterworth RF. Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy. Neurochem. Int. 57(4), 383-388 (2010).
51. Butterworth RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 53(4), 1372-1376 (2011).
52. Haberle J, Gorg B, Rutsch F et al. Congenital glutamine deficiency with glutamine synthetase mutations. N. Engl. J. Med. 353(18), 1926-1933 (2005).
53. Oide T, Yoshida K, Kaneko K, Ohta M, Arima K. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia. Neuropathol. Appl. Neurobiol. 32(2), 170-176 (2006).
54. Yin Z, Milatovic D, Aschner JL et al. Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes. Brain Res. 1131(1), 1-10 (2007).
55. Struys-Ponsar C, Guillard O, van den Bosch de Aguilar P. Effects of aluminum exposure on glutamate metabolism: a possible explanation for its toxicity. Exp. Neurol. 163(1), 157-164 (2000).
56. Suarez-Fernandez MB, Soldado AB, Sanz-Medel A, Vega JA, Novelli A, Fernandez-Sanchez MT. Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res. 835(2), 125-136 (1999).
57. Oberheim NA, Tian GF, Han X et al. Loss of astrocytic domain organization in the epileptic brain. J. Neurosci. 28(13), 3264-3276 (2008).
58. Carmignoto G, Haydon PG. Astrocyte calcium signaling and epilepsy. Glia 60(8), 1227-1233 (2012).
59. Coulter DA, Eid T. Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 60(8), 1215-1226 (2012).
60. Heinemann U, Kaufer D, Friedman A. Blood-brain barrier dysfunction, TGFb signaling, and astrocyte dysfunction in epilepsy. Glia 60(8), 1251-1257 (2012).
61. Seifert G, Carmignoto G, Steinhauser C. Astrocyte dysfunction in epilepsy. Brain Res. Rev. 63(1-2), 212-221 (2010).
62. Seifert G, Steinhauser C. Neuron-astrocyte signaling and epilepsy. Exp. Neurol. doi:10.1016/j.expneurol.2011.08.024 (2011) (Epub ahead of print).
63. Reyes RC, Parpura V. Models of astrocytic Ca dynamics and epilepsy. Drug Discov. Today Dis. Models 5(1), 13-18 (2008).
64. Heneka MT, Rodriguez JJ, Verkhratsky A. Neuroglia in neurodegeneration. Brain Res. Rev. 63(1-2), 189-211 (2010).
65. Rodriguez JJ, Verkhratsky A. Neuroglial roots of neurodegenerative diseases? Mol. Neurobiol. 43(2), 87-96 (2011).
66. Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ. Astrocytes in Alzheimer's disease. Neurotherapeutics 7(4), 399-412 (2010).
67. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiat. Psych.-Gericht. Med. 64, 146-148 (1907).
68. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol. Aging 25(5), 663-674 (2004).
69. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission? Mol. Neurodegener. 6, 55 (2011).
70. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323(5918), 1211-1215 (2009).
71. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 58, 831-838 (2010).
72. Yeh CY, Vadhwana B, Verkhratsky A, Rodriguez JJ. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN Neuro. 3(5), 271-279 (2012).
73. Kulijewicz-Nawrot M, Verkhratsky A, Chvatal A, Sykova E, Rodriguez JJ. Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J. Anat. 221(3), 252-262 (2012).
74. Terry RD. Cell death or synaptic loss in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59(12), 1118-1119 (2000).
75. Heneka MT, Sastre M, Dumitrescu-Ozimek L et al. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J. Neuroinflam. 2(1), 22 (2005).
76. Rossner S, Lange-Dohna C, Zeitschel U, Perez-Polo JR. Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme. J. Neurochem. 92(2), 226-234 (2005).
77. Rossi D, Brambilla L, Valori CF et al. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 15(11), 1691-1700 (2008).
78. Rossi D, Volterra A. Astrocytic dysfunction: Insights on the role in neurodegeneration. Brain Res. Bull. 80, 224-232 (2009).
79. Staats KA, Van Den Bosch L. Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival. J. Biol. Phys. 35(4), 337-346 (2009).
80. Yamanaka K, Chun SJ, Boillee S et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11(3), 251-253 (2008).
81. Wang L, Gutmann DH, Roos RP. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum. Mol. Genet. 20(2), 286-293 (2011).
82. Hazell AS, Sheedy D, Oanea R et al. Loss of astrocytic glutamate transporters in Wernicke encephalopathy. Glia 58, 148-156 (2009).
83. Hazell AS. Astrocytes are a major target in thiamine deficiency and Wernicke's encephalopathy. Neurochem. Int. 55(1-3), 129-135 (2009).
84. Broe M, Kril J, Halliday GM. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 127(Pt 10), 2214-2220 (2004).
85. Kersaitis C, Halliday GM, Kril JJ. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol. 108(6), 515-523 (2004).
86. Potts R, Leech RW. Thalamic dementia: an example of primary astroglial dystrophy of Seitelberger. Clin. Neuropathol. 24(6), 271-275 (2005).
87. Rosenbaum AI, Maxfield FR. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J. Neurochem. 116(5), 789-795 (2011).
88. McGeer PL, McGeer EG. Glial reactions in Parkinson's disease. Mov. Disord. 23(4), 474-483 (2008).
89. Mena MA, Garcia de Yebenes J. Glial cells as players in parkinsonism: the 'good', the 'bad' and the 'mysterious' glia. Neuroscientist 14(6), 544-560 (2008).
90. Estrada-Sánchez AM, Rebec GV. Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. Basal Ganglia 2(2), 57-66 (2012).
91. Bernstein HG, Steiner J, Bogerts B. Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev. Neurother. 9(7), 1059-1071 (2009).
92. Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets 6(3), 219-233 (2007).
93. Miljkovic D, Timotijevic G , Mostarica Stojkovic M. Astrocytes in the tempest of multiple sclerosis. FEBS Lett. 585(23), 3781-3788 (2011).